TOMI Environmental Solutions announced a collaboration with Cellares to integrate its SteraMist ionized Hydrogen Peroxide technology into a revolutionary new cell therapy manufacturing solution, the Cell Shuttle, designed and produced by Cellares. Due to the critical importance of maintaining a sterile environment within the confined spaces of the Cell Shuttle, Cellares selected TOMI’s patented iHP decontamination technology. The SteraMist iHP technology ensures comprehensive decontamination with its small micron particles, offering advantages in efficacy and safety over other commercially available decontamination methods. “Our collaboration with TOMI and SteraMist iHP technology has been instrumental in bringing effective decontamination to the Cell Shuttle,” stated Daniele Malleo, PhD, VP of Research & Development at Cellares. “We are confident that our design, coupled with the SteraMist iHP decontamination, will set the standard for cell-therapy manufacturing in the industry.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on TOMZ:
- TOMI Announces Preliminary Second Quarter Revenue Growth of 90%
- Tomi Environmental Solutions sees Q2 revenue $2.8M vs. $1.3M last year
- Tomi Environmental enters partnership with International Business Development
- TOMI Expands Distribution Channels with Additional Partner in Italy
- TOMI Secures Vizient Contract as an Approved Supplier of SteraMist Systems for Nationwide Healthcare Networks